Endothelial Dysfunction as a Primary Consequence of SARS-CoV-2 Infection.

Area of Science:

• Vascular Biology
• Virology
• Immunology

Background:

• Multiple viral species impact the endothelium, the inner lining of blood vessels.
• Seven human endemic coronaviruses cause respiratory diseases and interact with endothelial receptors.
• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly infectious and targets angiotensin-converting enzyme-2 (ACE-2) on endothelial cells.

Purpose of the Study:

• To investigate the effects of SARS-CoV-2 infection on endothelial cells and vascular integrity.
• To understand the mechanisms linking viral infection, endothelial dysfunction, and COVID-19 severity.
• To explore potential therapeutic targets for COVID-19 related to the endothelium and coagulation.

Main Methods:

• Review of existing literature on viral infections and endothelial effects.
• Analysis of SARS-CoV-2 binding to ACE-2 receptors on endothelial cells.
• Examination of the impact of cytokine storms and endothelial apoptosis on vascular integrity.

Main Results:

• SARS-CoV-2 infection induces endothelial apoptosis and functional changes, compromising vascular integrity in multiple organs.
• Endothelial damage promotes coagulation, leading to thrombus formation.
• COVID-19 outcomes are worse in patients with comorbidities like hypertension and diabetes, possibly due to pre-existing endothelial dysfunction.

Conclusions:

• SARS-CoV-2 significantly damages the endothelium, contributing to severe COVID-19.
• Endothelial dysfunction and inflammation are key factors in COVID-19 pathogenesis and severity.
• Targeting the endothelium, inflammation, and coagulation pathways are promising therapeutic strategies for COVID-19.